Technology Feature | Agreeable antibodies: Antibody validation challenges and solutions

Commercially produced antibodies have become workhorses of basic research, but opaque supply chains, a lack of clear quality standards, and scientists' complacency have turned antibody-based experiments into potential disaster zones. Several strategies can help researchers navigate past these pitfalls. Read the Feature (Full-Text HTML) Read the Feature (PDF) Read New Products (PDF)